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Abstract: Interspecies transmission of pathogens may
result in the emergence of new infectious diseases in
humans as well as in domestic and wild animals.
Genomics tools such as high-throughput sequencing,
mRNA expression profiling, and microarray-based analysis
of single nucleotide polymorphisms are providing un-
precedented ways to analyze the diversity of the genomes
of emerging pathogens as well as the molecular basis of
the host response to them. By comparing and contrasting
the outcomes of an emerging infection with those of
closely related pathogens in different but related host
species, we can further delineate the various host
pathways determining the outcome of zoonotic trans-
mission and adaptation to the newly invaded species. The
ultimate challenge is to link pathogen and host genomics
data with biological outcomes of zoonotic transmission
and to translate the integrated data into novel interven-
tion strategies that eventually will allow the effective
control of newly emerging infectious diseases.
Emerging Zoonotic Viruses
Most of the well-known human viruses persist in the population
for a relatively long time, and coevolution of the virus and its
human host has resulted in an equilibrium characterized by
coexistence, often in the absence of a measurable disease burden.
When pathogens cross a species barrier, however, the infection
can be devastating, causing a high disease burden and mortality.
In recent years, several outbreaks of infectious diseases in humans
linked to such an initial zoonotic transmission (from animal to
human host) have highlighted this problem. Factors related to our
increasingly globalized society have contributed to the apparently
increased transmission of pathogens from animals to humans over
the past decades; these include changes in human factors such as
increased mobility, demographic changes, and exploitation of the
environment (for a review see Osterhaus [1] and Kuiken et al. [2]).
Environmental factors also play a direct role, and many examples
exist. The recently increased distribution of the arthropod
(mosquito) vector Aedes aegypti, for example, has led to massive
outbreaks of dengue fever in South America and Southeast Asia.
Intense pig farming in areas where frugivorous bats are common is
probably the direct cause of the introduction of Nipah virus into
pig populations in Malaysia, with subsequent transmission to
humans. Bats are an important reservoir for a plethora of zoonotic
pathogens: two closely related paramyxoviruses—Hendra virus
and Nipah virus—cause persistent infections in frugivorous bats
and have spread to horses and pigs, respectively [3].
The similarity between human and nonhuman primates permits
many viruses to cross the species barrier between different primate
species. The introduction into humans of HIV-1 and HIV-2 (the
lentiviruses that cause AIDS), as well as other primate viruses, such
as monkeypox virus and Herpesvirus simiae, provide dramatic
examples of this type of transmission. Other viruses, such as
influenza A viruses and severe acute respiratory syndrome
coronavirus (SARS-CoV), may need multiple genetic changes to
adapt successfully to humans as a new host species; these changes
might include differential receptor usage, enhanced replication,
evasion of innate and adaptive host immune defenses, and/or
increased efficiency of transmission. Understanding the complex
interactions between the invading pathogen on the one hand and
the new host on the other as they progress toward a new host–
pathogen equilibrium is a major challenge that differs substantially
for each successful interspecies transmission and subsequent
spread of the virus.
Genomics of Zoonotic Viruses and Their Hosts
New molecular techniques such as high-throughput sequencing,
mRNA expression profiling, and array-based single nucleotide
polymorphism (SNP) analysis provide ways to rapidly identify
emerging pathogens (Nipah virus and SARS-CoV, for example)
and to analyze the diversity of their genomes as well as the host
responses against them. Essential to the process of identification
and characterization of genome sequences is the exploitation of
extensive databases that allow the alignment of viral genome
sequences and the linkage of these genomics data to those obtained
by classical viral culture and serological techniques, and
epidemiological, clinical, and pathological studies [4]. Extensive
genetic analysis of HIV-1, for example, has provided clues to the
geography and time scale of the early diversification of HIV-1
strains when the virus emerged in humans. HIV-1 strains are
divided into multiple clades, each of which has independently
evolved from a simian immunodeficiency virus (SIV) that naturally
infects chimpanzees in West and Central Africa. Current estimates
date the common ancestor of HIV-1 to the beginning of the
twentieth century [5].
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clinical outcomes in human hosts that differ in age, nutritional
status, genetic background, and immunological condition, deci-
phering the complex interactions between evolving pathogens and
their hosts is a great challenge. The genome sequences of many
host species have become available the last decade, and with them
a range of novel tools are available to study virus–host interactions
at the molecular level. This progress, together with advances in
high-throughput sequencing technology and, not least, in
(bio)informatics and statistics, allows us to analyze the ‘‘genome-
wide’’ networks of gene interactions that control the host response
to pathogens. By comparing and contrasting the outcomes of
infection with closely related pathogens in different but related
host species, we can further delineate the various host pathways
involved in the different outcomes. The power of this approach
was nicely demonstrated for SIV infection of various primate host
species. Natural reservoir hosts of SIV do not develop AIDS upon
infection, whereas non-natural hosts, such as rhesus macaques and
pig-tailed macaques, when infected experimentally with SIV,
develop AIDS in a similar manner to HIV-infected humans.
Transcriptional profiling indicates that SIV infection of these
species produces a distinctive host response [6]. SIV-infected
primates with symptoms of AIDS have a high viral load, immune
activation, and loss of certain types of T cells, whereas SIV-
infected sooty mangabeys (the species from which HIV-2 is
thought to have originated) have substantially lower levels of
innate immune activation than the symptomatic primates, partly
due to the production of less interferon-a by plasmacytoid
dendritic cells in response to SIV and other Toll-like receptor
ligands [7]. Identification of host factors that restrict HIV infection
may aid the development of effective intervention strategies.
Below, we elaborate on two other examples of recent important
zoonotic events that led to sustained virus transmission in the
human host, and the role that genomics has played in the
elucidation of their pathogenesis thus far.
Influenza Virus
Influenza is caused by RNA viruses of the Orthomyxoviridae
family. Whereas fever and coughs are the most frequent
symptoms, in more serious cases a fatal pneumonia can develop,
particularly in the young and the elderly. Typically, influenza is
transmitted through the air by coughs or sneezes, creating aerosols
containing the virus; but influenza can also be transmitted by bird
droppings, saliva, feces, and blood. Birds and pigs play an
important role in the emergence of new influenza viruses in
humans. Fecal sampling of migratory birds has revealed that they
harbor a large range of different subtypes of influenza A viruses
[8]. Some wild duck species, particularly mallards, are potential
long-distance vectors of highly pathogenic avian influenza virus
(H5N1), whereas others, including diving ducks, are more likely to
act as ‘‘sentinel’’ species that die upon infection [9]. Following the
introduction of a new pandemic influenza A virus subtype from an
avian reservoir, either directly or via another mammalian species
such as the pig, the virus may continue to circulate in humans in
subsequent years as a seasonal influenza virus. In the past century,
three major influenza epidemics resulted in the loss of many
millions of lives. Spanish flu alone caused the deaths of more than
50 million people by the end of World War I in 1918. The 2009
outbreak of a new H1N1 virus (causing ‘‘swine flu’’) that started in
Mexico further illustrates the pandemic potential of influenza A
viruses.
After introduction of a new influenza A virus from an avian or
porcine reservoir into the human species, viral genomics studies
are essential to identify critical mutations that enable the
circulating virus to spread efficiently, interact with different
receptors, and cause disease in the new host. For example, the
importance of residue 627 of the PB2 protein of the viral
polymerase in determining species restriction has been demon-
strated through these kinds of approaches [10]. Furthermore,
changes in the hemagglutinin molecules may allow influenza A
viruses to switch receptor specificity. The hemagglutinin of avian
H5N1 influenza viruses preferentially binds to oligosaccharides
that terminate with a sialic acid–a-2,3-Gal disaccharide, whereas
the hemagglutinins of mammalian influenza A viruses prefer
oligosaccharides that terminate with sialic acid–a-2,6-Gal
(Figure 1). Fatal viral pneumonia in humans infected with avian
H5N1 viruses is partly due to the ability of these viruses to attach
to and replicate in the cells of the lower respiratory tract, which
have oligosaccharides that terminate in sialic acid–a-2,3-Gal
disaccharide [11,12]. The sequence of the hemagglutinin protein
may also affect its binding affinity for neutralizing antibodies.
Understanding the relationship between genetic diversity and
antigenic properties of these viruses [13] may help to predict the
emergence of influenza viruses and to develop effective vaccines.
Microarray-assisted mRNA expression profiling of emerging
zoonotic viral infections, including influenza A virus, is used to
phenotype the host response in great detail. By comparing mRNA
expression in individuals infected with an emerging virus to
expression in individuals infected with a related established virus,
researchers can generate a ‘‘molecular fingerprint’’ of the host
response genes or pathways specifically involved in the often-
exuberant host responses to the emerging virus. By using
genetically engineered influenza A viruses, a role for the
nonstructural NS1 viral protein in evasion of the innate host
response has been demonstrated [14]. Interestingly, the NS1
protein derived from the 1918 Spanish H1N1 pandemic influenza
virus blocked expression of interferon-regulated genes more
efficiently than did the NS1 protein from established seasonal
influenza viruses [14]. Other genomics studies of genetically
engineered influenza A viruses containing some or all of the gene
segments from either the 1918 H1N1 virus or the highly
pathogenic avian influenza A virus (H5N1), suggest that these
highly pathogenic influenza viruses induce severe disease in mice
and macaques through aberrant and persistent activation of
proinflammatory cytokine and chemokine responses [15–18].
Application of genomics tools not only supports the elucidation
of mechanisms underlying pathogenesis but may also help to
identify leads for therapeutic intervention. In ferrets, H5N1
infection induced severe disease that was associated with strong
expression of interferon response genes including the interferon-c-
induced cytokine CXCL10. Treatment of H5N1-infected ferrets
with an antagonist of the CXCL10 receptor (CXCR3) reduced the
severity of the flu symptoms and the viral titers compared to the
controls [19], clearly demonstrating the potential of biological
response modifiers for the clinical management of viral infections.
The host evasion and evolution of influenza virus is further
discussed in [20].
SARS-CoV
Coronaviruses (CoVs) primarily infect the upper respiratory and
gastrointestinal tract of mammals and birds. Five different
currently known CoVs infect humans and are believed to cause
a significant percentage of all common colds in human adults.
Surprisingly, recent studies revealed that approximately 6% of bats
sampled in China were positive for CoVs [21]. Subsequent
phylogenetic studies revealed that bat CoVs that resembled
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subgroup of bat CoVs and another of SARS-CoVs from humans
and other mammalian hosts. According to the current hypothesis
SARS-CoV has arisen by recombination between two bat viruses.
Phylogenetic analysis of SARS-CoV isolates from animals indicate
that the resulting bat virus was transmitted first to palm civets
(Paguma larvata), a wild cat-like animal hunted for its meat, and
subsequently to humans at live animal markets in southern China
[22].
Genome analyses have provided evidence that genetic variation
in the spike gene of these viruses from civets is associated with
increased transmission of the virus [21]. In addition, species-to-
species variation in the sequence of the gene angiotensin-converting
enzyme 2 (ACE2), which encodes the SARS-CoV receptor, also
affects the efficiency by which the virus can enter cells [23]. By a
combination of phylogenetic and bioinformatics analyses, chimeric
gene design, and reverse genetics–aided generation of viruses that
encode spike proteins of diverse isolates, researchers have
reconstructed the events that led to the emergence of a virus able
to spread efficiently in humans [24]. Structural modeling predicted
that the SARS-CoV that caused the epidemic had an increased
affinity for both civet and human ACE2 receptors due to
adaptation (Figure 2). Subsequent functional genomics studies of
these viruses in diverse species provided further insight into the
role of specific host genes involved in the pathogenic response
[25,26]. The pathological changes observed in the lungs are
initiated by a disproportionate innate immune response, illustrated
by elevated levels of inflammatory cytokines and chemokines, such
Figure 1. Zoonotic transmission of influenza A virus. The hemagglutinin of avian influenza A viruses (blue) preferentially bind to
oligosaccharides that terminate in sialic acid–a-2,3-Gal (red), whereas the hemagglutinin on human influenza A viruses (green) prefer
oligosaccharides that terminate in sialic acid–a-2,6-Gal (orange). Fatal viral pneumonia in humans infected with the H5N1 subtype of avian
influenza A viruses is likely due to the ability of these viruses to attach to and replicate in the lower respiratory tract cells, which have sialic acid-a-2,3-
Gal terminated saccharides. The horizontal arrows indicate interspecies transmission, including the transmission from an avian or porcine reservoir
into the human species. Image credit: Bart Haagmans, Erasmus MC. Original images (left to right, from top to bottom) by Roman Ko ¨hler, Alvesgaspar,
Anton Holmquist, Joshua Lutz, and CDC.
doi:10.1371/journal.ppat.1000557.g001
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12, IL-1b, and interferon-c [27]. These clinical data were
confirmed experimentally by demonstrating that SARS-CoV
infection of diverse cell types induces a range of cytokines and
chemokines, thus providing a conceptual framework for SARS-
CoV pathogenesis. Host genome expression analyses of various
animal hosts and humans with different outcomes of infection
indicated differential activation of innate immune genes in, for
example, aged subjects compared to young subjects. Importantly,
treatment of aged macaques with pegylated interferon-a (i.e.
interferon-a covalently modified with polyethylene glycol polymer
chains, to enhance its bioavailability) reduced SARS-CoV
replication and pathogenic responses [28]. Thus, host genomics
analysis may provide markers of pathogenesis and leads for
therapeutic intervention, as in this example of SARS-CoV
infection.
Challenges for the Future
Rapid identification of newly emerging viruses through the use
of genomics tools is one of the major challenges for the near future.
In addition, the identification of critical mutations that enable
viruses to spread efficiently, interact with different receptors, and
cause disease in diverse hosts through, for instance, enhanced viral
replication or circumvention of the innate and adaptive immune
responses, needs to be further expanded. Although microarray-
assisted transcriptional profiling can provide us with a wealth of
information regarding host genes and gene-interacting networks in
Figure 2. Zoonotic transmission of SARS-CoV. Genomic analyses provided evidence that genetic changes in the spike gene of SARS-CoV from
bats (left) and civet cats (center) are essential for the animal-to-human transmission (horizontal arrows). Species-to-species genetic variation in the
(thus far unidentified) viral receptor in bats and in the angiotensin converting enzyme 2 (ACE2) gene, encoding the SARS-CoV receptor in civet cats and
humans also affects the efficiency with which the virus can enter cells (vertical arrows). The SARS-CoV that caused the epidemic evolved a high
affinity for both civet (center) and human (right) ACE2 receptors (indicated by the single diagonal and the right side vertical arrow). Image credit: Bart
Haagmans, Erasmus MC. Original images (left to right) by Dodoni, Paul Hilton, and Hoang Dinh Nam.
doi:10.1371/journal.ppat.1000557.g002
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data obtained in different experimental settings. Therefore, the
careful design of complementary sets of experiments using
different formats of virus–host interactions is absolutely needed
for successful genomics studies [29]. Special attention should be
addressed to the comparative analysis of the host response in
diverse animal species. Thus far a limited number of laboratory
animal species has been studied, but the recent elucidation of the
genome of several other animal species will provide tools to
decipher the virus–host interactions in the more relevant natural
host. Recent developments in the sequencing of the RNA
transcriptome may aid this development. Ultimately, microarray
technology may also extend to genotyping of the human host by
SNP analysis, to identify markers of host susceptibility and severity
of disease, that can be used in tailor-made clinical management of
disease caused by emerging infections. Comparative analysis of
host responses to emerging viruses may also point toward a similar
dysregulated host response to a range of emerging virus infections,
enabling the rational design of multipotent biological response
modifiers to combat a variety of emerging viral infections. By
focusing on broad-acting intervention strategies rather than on the
discovery of a newly emerging pathogen that is not characterized
yet, we may be able to protect ourselves from several unexpectedly
emerging infections with the same clinical manifestations. This
approach may readily reduce the burden of disease and time will
be gained to design preventive pathogen specific intervention
strategies such as antiviral therapy or vaccination. Clearly, for all
stages of combating emerging infections, from the early identifi-
cation of the pathogen to the development and design of vaccines,
application of sophisticated genomics tools is fundamental to
success.
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